Nanose Medical

Nanose sviluppa una piattaforma di rilevamento basata sull'intelligenza artificiale che consente la rilevazione precoce del rischio di cancro ai polmoni e fibrosi epatica avanzata (MASLD/MASH) nel punto di cura.

La nostra tecnologia di rilevamento proprietaria genera un'impronta biochimica del respiro da un campione di 30 secondi con risultati in meno di 5 minuti , consentendo una stratificazi...

Per saperne di più

Paese

Israel

Sito web

nanosemed.com

Fondato

2019

Social

Fonte delle informazioni:

https://nanosemed.com/

Aggiungi alla mia lista

Dirigenti chiave

Ilay Marom

Co-founder & COO

Orit Marom Albeck

Co-Founder and CEO

Imad Telhami

Co-Founder & Board member

Settori

Biotech

Med Tech

GoforIsrael

Ultime Notizie e attività

News Feb , 2022

The Marker - ה"אף האלקטרוני" יציל חיים: החיישנים הננו-מטריים יתריעו על מחלות וזיהומים באמצעות הרחה בלבד

News May , 2025

ctech - "Running a startup is like going to war—you need teammates who don’t give up when things get hard" | CTech

News Jun , 2025

ctech - “We want to be in every clinic”: The Israeli startup out to change early disease detection | CTech

Aggiungi la tua azienda

Disclaimer

The content of this website is not directed at or intended for persons in the United Kingdom or any other jurisdiction where the provision of the website or services would breach any applicable law or registration or would require any registration or license in any such jurisdiction. The content of this website should not be regarded as an invitation or inducement to engage in investment activity, to any person in the United Kingdom and investment opportunities described on this website are not intended to be acted upon by any persons in the United Kingdom.